Who invested in Macrolide Pharmaceuticals?
Macrolide Pharmaceuticals's investors include Novartis Venture Fund, SR One, Roche Venture Fund and Gurnet Point Capital.
United States · Series A startup
One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$22Mraised across 1 round since 2015, from 1 source
From a historical funding recordSEC filing: $8.2M sold, first sale Feb 2015
Macrolide Pharmaceuticals's investors include Novartis Venture Fund, SR One, Roche Venture Fund and Gurnet Point Capital.
Macrolide Pharmaceuticals has raised $22M across 1 round since 2015.
Macrolide Pharmaceuticals's most recent round was a Series A of $22M in Mar 2015.
Its most recent round, $22M in Mar 2015, is also its largest on record.
Macrolide Pharmaceuticals's first round on record, in Mar 2015, was backed by Novartis Venture Fund, SR One and Roche Venture Fund and 1 others.
Macrolide Pharmaceuticals's latest named round is a Series A, in Mar 2015.
Macrolide Pharmaceuticals is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.